Moneycontrol
HomeNewsTrendsXE variant of Covid-19: Here’s all you need to know about this sub-variant of Omicron
Trending Topics

XE variant of Covid-19: Here’s all you need to know about this sub-variant of Omicron

XE is a sub-variant of Omicron. Here is what we know so far about the XE variant of Covid-19

April 10, 2022 / 13:56 IST
Story continues below Advertisement

Here is all you need to know about the XE variant of Covid-19 (Representative Image)

Recently, a person in Gujarat was found to be infected with the XE variant of coronavirus - just days after India reported its first case of the variant in Mumbai. The Health Ministry, however, had denied the Mumbai report, saying that the "present evidence does not suggest the presence of the new variant". The cases have sparked fears of a new wave of coronavirus infections in the country - but is it too soon to start worrying? Here is everything we know so far about the XE variant of coronavirus:

What is the XE variant of coronavirus?

Story continues below Advertisement

XE is a sub-variant of Omicron, which caused a third wave of infections in India this winter.

Omicron has two prominent subvariants - BA.1 and BA.2. While BA.1 is the original strain, BA.2 is more infectious and widespread.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show